- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Conrad C Axelrod
News 8 results
Cases & Deals
August 24, 2021
Arbor Pharmaceuticals to Merge with Azurity Pharmaceuticals
Cases & Deals
August 9, 2021
King & Spalding Team Closes a Variety of Esoteric Financings in Early 2021
In the News · Source: Global Legal Chronicle
December 2, 2020
K&S counsels MAG Mutual Insurance Company on its acquisition of West Virginia Mutual Insurance Company
Press Release
December 5, 2019
King & Spalding Elects 21 New Partners and Promotes Four Counsel Across Eight Offices
Events 1 results
Speaking Engagement
February 15, 2022
Conrad Axelrod to Speak on IFI Global and Jersey Finance Virtual Roundtable
Insights 5 results
Thought Leadership
April 20, 2022
Checklist for Non-U.S. Fund Managers Making a Private Fund Offering in the U.S.
Client Alert
March 22, 2022
SEC Investment Adviser Marketing Rule: Compliance Date is Nov. 4, 2022
Client Alert
February 24, 2022
SEC Issues Significant Private Fund Proposal: Standardized Prohibitions and Requirements
Client Alert
April 1, 2021
SEC Division of Examinations – 2021 Priorities